Repigmentation of vitiligo during efalizumab.
Wakkee
Marlies
M
Assen
Yvette J
YJ
Thio
H Bing
HB
Neumann
H A Martino
HA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects*; D014820:Vitiligo / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab